METACRINE, INC. SEPARATION AND CONSULTING AGREEMENTSeparation and Consulting Agreement • January 28th, 2022 • Metacrine, Inc. • Pharmaceutical preparations • California
This Separation and Consulting Agreement (this “Agreement”) is effective as of January 27, 2022 (“Effective Date”), by and between Metacrine, Inc., a Delaware corporation (the “Company”) located at 3985 Sorrento Valley Blvd, Suite C, San Diego, California 92121, and Catherine Lee (“Lee” or “Consultant”) an individual with the address on file with the Company.
